Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease.
暂无分享,去创建一个
D. Rubin | R. Shilling | S. White | S. Sohi
[1] U. Mahadevan,et al. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease. , 2005, Inflammatory bowel diseases.
[2] B. Korelitz,et al. Diffuse Alveolar Hemorrhage After Infliximab Treatment of Crohn's Disease , 2004, Inflammatory bowel diseases.
[3] A. Kimball,et al. Counter-regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy. , 2004, Journal of drugs in dermatology : JDD.
[4] P. Chanez,et al. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? , 2003, European Respiratory Journal.
[5] S. Kakar,et al. Noninfectious Lung Pathology in Patients With Crohn's Disease , 2003, The American journal of surgical pathology.
[6] I. Baig. Infliximab induced eosinophilic pleural effusion in inflammatory bowel disease , 2002 .
[7] J. Viallard,et al. Churg-Strauss syndrome in two patients receiving montelukast. , 2002, Rheumatology.
[8] John A. Godfrey,et al. Delayed Hypersensitivity Reaction and Acute Respiratory Distress Syndrome Following Infliximab Infusion , 2002, Inflammatory bowel diseases.
[9] P. Weller,et al. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. , 2001, The Journal of allergy and clinical immunology.
[10] A. Warris,et al. Invasive pulmonary aspergillosis associated with infliximab therapy. , 2001, The New England journal of medicine.
[11] R. Pauwels,et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. , 2000, Chest.
[12] J. Franco,et al. Pulmonary eosinophilia associated with montelukast , 1999, Thorax.
[13] M. Reynaud‐Gaubert,et al. Idiopathic Chronic Eosinophilic Pneumonia: A Clinical and Follow‐Up Study of 62 Cases , 1998, Medicine.
[14] J. Drazen,et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. , 1998, JAMA.
[15] M. Wewers,et al. Detection of IL-5 and IL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia. , 1996, The Journal of allergy and clinical immunology.
[16] E. Gaensler,et al. Chronic Eosinophilic Pneumonia A REPORT OF 19 CASES AND A REVIEW OF THE LITERATURE , 1988, Medicine.
[17] R. Venu,et al. Crohn's disease involving the lung: resolution with infliximab. , 2001, Digestive diseases and sciences.
[18] J. Keane,et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. , 2001, The New England journal of medicine.
[19] T. Colby,et al. The lung in inflammatory bowel disease. , 2000, The European respiratory journal.
[20] T. Honda,et al. IL-5 predominant in bronchoalveolar lavage fluid and peripheral blood in a patient with acute eosinophilic pneumonia. , 1995, Internal medicine.